If you have been exploring fertility options or consulting with a reproductive specialist after 35, there is a good chance you have encountered the term AMH — anti-Müllerian hormone. AMH testing has become one of the most commonly used tools in fertility assessment, and yet the results can feel difficult to interpret or even alarming when received without adequate context. This article aims to explain what AMH measures, what it can and cannot tell you, and how results are typically used in clinical practice.
It is important to say upfront: an AMH result — even one that is lower than expected — does not predict whether you will conceive, and it should never be interpreted in isolation. AMH is one piece of a complex fertility picture, and understanding its limitations is just as important as understanding what it measures.
What Is AMH and What Does It Measure?
Anti-Müllerian hormone is produced by granulosa cells in small follicles within the ovaries. Because these follicles represent the early-stage pool of eggs available in any given cycle, AMH levels serve as a proxy for ovarian reserve — essentially, a rough estimate of the remaining quantity of eggs.
According to research summarized by the National Institute of Child Health and Human Development, AMH levels tend to decline gradually with age as the ovarian reserve naturally decreases. This decline becomes more pronounced in the late 30s and accelerates further in the early 40s for most women, though there is considerable individual variation in the pace of this decline.
AMH has advantages over some older ovarian reserve markers because it remains relatively stable across the menstrual cycle — unlike FSH (follicle-stimulating hormone), which can vary considerably depending on cycle timing. This means AMH can be measured at any point in the cycle, making it practically convenient for testing.
How AMH Is Used in Fertility Assessment
In a fertility evaluation, AMH is typically used to:
- Estimate ovarian reserve — how many eggs may be available for natural conception or for retrieval in assisted reproductive procedures
- Guide decisions about the timing and type of fertility treatment
- Predict ovarian response to stimulation medications used in IVF
- Provide context for counseling about reproductive options and timelines
AMH is usually assessed alongside other markers, including antral follicle count (AFC) — a transvaginal ultrasound measurement of small follicles visible in the ovaries — and sometimes FSH and estradiol levels measured early in the menstrual cycle. Together, these provide a more complete picture of ovarian reserve than any single marker alone.
AMH and Natural Conception
One of the most important things to understand about AMH is what it cannot tell you: it cannot reliably predict the likelihood of natural conception for an individual woman. Several studies have found that AMH levels are not a strong predictor of time-to-pregnancy in women who are trying to conceive naturally. This is partly because natural conception requires only a single viable egg per cycle, and AMH primarily reflects quantity rather than quality.
Egg quality — which is more closely linked to age than to AMH level — is a critical factor in conception and early pregnancy success. A woman with a lower AMH for her age may still have excellent egg quality and conceive naturally, while a woman with a higher AMH may face challenges related to egg quality. This is why interpreting AMH in isolation can be misleading.
Understanding AMH Results: What the Numbers Mean
AMH is measured in nanograms per milliliter (ng/mL) or picomoles per liter (pmol/L), and reference ranges vary by laboratory. General reference ranges by age are used in some clinical settings, but individual variation is significant enough that a result labeled “low for age” may still be within a range consistent with successful natural conception or IVF response.
If you have received an AMH result that feels concerning, the most important step is to discuss it with a reproductive endocrinologist rather than interpreting it based on general internet ranges. The same numeric result means different things depending on age, clinical context, other fertility markers, and individual history.
What a “Low” AMH Result May Mean
A lower-than-expected AMH level suggests that ovarian reserve may be reduced, which in a clinical context may mean fewer eggs available for retrieval in IVF protocols and potentially a more limited response to ovarian stimulation. However, it does not mean:
- That natural conception is impossible
- That IVF will not work
- That pregnancy is not achievable
- That the eggs available are poor quality
Many women with low AMH conceive — both naturally and with assistance. The result is a data point that informs clinical decision-making, not a verdict.
AMH Changes and Lifestyle Factors
Research has explored whether lifestyle factors — including smoking, body weight, and nutritional status — influence AMH levels. Smoking has the most consistent evidence for a negative association with ovarian reserve. The effects of other factors are less clear.
It is worth noting that AMH reflects the number of follicles, not egg quality, and that egg quality is primarily influenced by age. Some companies and clinics market supplements as being able to “improve” ovarian reserve or AMH levels — but current evidence does not support the ability to meaningfully increase the number of eggs through supplementation. Egg quality, which is what matters most for conception, is a separate question from quantity, and the research on supplements affecting egg quality is also limited and mixed.
For context on the broader emotional aspects of navigating fertility assessments, the discussion in the emotional journey of trying to conceive after 35 may offer helpful perspective on processing difficult information.
When to Consider AMH Testing
AMH testing is most commonly pursued in the context of a fertility evaluation — typically when a woman is planning to conceive and wants to understand her reproductive picture, has been trying to conceive for 6+ months after 35, or is considering egg freezing and wants to assess her ovarian reserve before proceeding.
It is generally not a routine test outside of a fertility context — for example, it is not typically included in standard annual wellness blood panels, though some providers offer it on request. If you are curious about your ovarian reserve but are not actively trying to conceive or planning fertility treatment, discussing whether testing is appropriate and useful for your situation with your gynecologist is a good starting point.
For broader context on understanding fertility changes after 35, reviewing evidence-based resources can help you approach any testing or consultations with a clearer framework.
Frequently Asked Questions
Does AMH predict my chances of getting pregnant naturally?
AMH is not a reliable predictor of natural conception for individual women. Research has found that AMH levels do not consistently predict time-to-pregnancy in women trying to conceive without assistance. What AMH reflects is primarily egg quantity, not quality — and both quantity and quality matter for conception. A reproductive endocrinologist can help you understand what your AMH level means in the context of your full picture.
Can I improve my AMH level?
Current evidence does not support the ability to meaningfully increase AMH through lifestyle changes or supplementation, as AMH reflects the number of follicles — which is largely determined by genetics and age. However, avoiding known negative influences on ovarian reserve (particularly smoking) and maintaining overall health is generally recommended as part of preconception care, for many reasons beyond AMH.
Is AMH testing accurate?
AMH testing is generally considered a reliable marker of ovarian reserve when performed by a quality laboratory, and has the advantage of being relatively stable across the menstrual cycle. However, no single test perfectly characterizes ovarian reserve, and AMH should be interpreted alongside other markers and clinical assessment rather than in isolation.
How often should AMH be repeated?
This depends on your clinical situation. For women who are actively pursuing fertility treatment or monitoring ovarian reserve over time, repeat testing at intervals your specialist recommends may be appropriate. For those not in active treatment, the frequency and utility of retesting vary. Your provider can advise based on your specific circumstances.
Key Takeaways
- AMH is a marker of ovarian reserve — reflecting primarily egg quantity rather than egg quality, which is more directly influenced by age.
- AMH is not a reliable predictor of natural conception for individual women; many women with lower AMH conceive naturally.
- Results should be interpreted by a reproductive endocrinologist in the context of other fertility markers, age, and clinical history — not in isolation using general internet ranges.
- Egg quality, which is central to conception success, is not directly measured by AMH and is better correlated with age than with AMH level.
- AMH testing is most valuable in a fertility evaluation context and is not typically a routine screening test — discuss with your provider whether testing is appropriate for your situation.
Medical Disclaimer
This content is for informational purposes only and does not constitute medical advice. Individual health situations vary significantly. Always consult a qualified healthcare provider before making decisions related to your health, fertility, or pregnancy.
About the Author
Emily Carter is a women’s health writer focused on fertility, pregnancy after 35, and sleep changes in midlife. She writes research-informed, non-alarmist content to help women navigate reproductive and hormonal transitions with clarity and confidence.